Our co-founders Lara and Thang have been named in the annual ‘200 Trailblazing Leaders in Women’s Health and FemTech’ for the third year running. It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide. We’re delighted at the recognition for Lara & Thang and of …

We’re delighted to share that our co-founder Lara was crowned the winner of the 🔥 Ignite Fire Pitch Competition, held during J.P. Morgan Week in San Francisco 🇺🇸 Ignite is a U.S. non-profit with a powerful mission: increasing the number of women leading and innovating the future of healthcare. The Ignite Fire Pitch represents the …

✨ Big congratulations to our board advisor Prof/Dr Annalisa Jenkins OBE on being recognised in the King’s New Year Honour’s List! Over more than 25 years, Annalisa has been an outstanding leader in the life sciences– building and guiding teams that have successfully taken programmes from early scientific discovery through clinical development, regulatory approval, and …

👏 CLCC is proud to share that we’ve successfully completed our ISO 9001 audit with *zero* major or minor non-conformities for the *third* year in a row. Quality has always been and will always be one of the core pillars of our company, and this result is a testament to the commitment, rigour, and consistency …

original article here: https://roivantsv.org/news/diversity-in-pharma-spotlight-naomi-aduroja Roivant Social Ventures (RSV) and Calla Lily Clinical Care have partnered to host the Global Access Fellowship Program, providing real-world drug development experience to talented PharmD students who are passionate about leveraging their career development to expand healthcare access to underserved patient groups. Calla Lily Clinical Care is transforming drug delivery …

original case study here: https://iuk-business-connect.org.uk/casestudy/innovate-uk-helps-calla-lily-bloom-in-womens-health/   Calla Lily Clinical Care is reshaping how vaginally administered drugs are delivered, starting with miscarriage prevention and fertility. With tailored business growth support from Innovate UK Business Growth, the London-based medical device company has secured £2.2 million in grant funding and more than £4.5 million in private investment, and …

Under the direction of co-founders Dr Lara Zibners and Thang Vo-Ta is reimagining vaginal drug delivery with its CallavidⓇ device—engineering a next-generation platform that improves both clinical outcomes and patient experience in women’s health. “Our revolutionary Callavid platform hugely increases the possibilities for intravaginal drug delivery by enabling treatments with enhanced efficacy, lower drug doses, …

[Original post here from Health Innovation Insider] In each edition, we delve into the minds of those who are redefining the boundaries of health. Our goal is to share the insights and stories of those leading the way to achieve the highest attainable standard of health and wellbeing for everyone. In this edition of Health …

Delighted to be named a 2025 finalist in the HLTH Europe Startup Pitch, sponsored by Haleon! Honoured to share the stage with some of the most innovative healthtech startups in Europe. See you in Amsterdam. 🇳🇱

We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …